The blood–brain barrier (BBB) inhibits most medications from reaching the brain. The epithelial-like tight junctions inside the brain capillary endothelium are responsible for this feature. The BBB is physically and physiologically separate from the choroid plexus' blood–cerebrospinal fluid barrier. The blood-brain barrier (BBB) is a dynamic structure that acts as a gatekeeper and reflects the brain's specific requirements. The presence of the BBB makes developing novel medicines for brain diseases or new radiopharmaceuticals for brain imaging challenging. Biotechnology produces only large molecule medications that do not cross the BBB. While it is commonly considered that small molecules travel freely through the BBB, only about 98 percent of all small molecules do so.
- Nanoparticle Delivery Across The BBB
- Brain Penetration and Drug Delivery
- The Blood-Brain Barrier in States of Disease
- Novel Approaches for BBB Models
A C Matin
Stanford University School of Medicine, Canada
Consolato M Sergi
University of Ottawa, Canada
Sergey Suchkov
University of Medicine & Dentistry, Russian Federation
Hans Christian Siebert
Research Institute of Bioinformatics and Nanotechnology (RIBNT), Germany
Ekaterina Aleksandrovna Pashkina
Research Institute of Fundamental and Clinical Immunology, Russian Federation
Swati Sachin Mutha
Vishwakarma University, India
Phila Raharivelomanana
University of French Polynesia, French Polynesia
Mridula Prakash Menon
National Ilan University, Taiwan
Jian Yu Chen
Fujian University of Traditional Chinese Medicine, China
Naseratun Nessa
Kyoto Prefectural University of medicine, JapanSubmit your abstract Today
Title : mRNA and exosome-mediated directed gene therapy of cancer with no side effects
A C Matin, Stanford University School of Medicine, Canada
Title : Assessment of Marquesan Rauvolfia nukuhivensis bioactive content
Phila Raharivelomanana, University of French Polynesia, French Polynesia
Title : Antibody-Proteases as Translational Tools of The Newest Generation to be applied for Biodesign and Bioengineering to get Precision and Personalized Healthcare Services Re-armed
Sergey Suchkov, University of Medicine & Dentistry, Russian Federation
Title : Nano modification of Antrodia cinnamomea exhibit anti-inflammatory action and improves the migratory potential of myogenic progenitors
Mridula Prakash Menon, National Ilan University, Taiwan
Title : Preparation and Optimization of Oral Lyophilized Flash Tablets Loaded with Sildenafil Citrate Self Nanoemulsifying System
Maeen Abdulaziz Almodhwahi, King Abdulaziz University, Saudi Arabia
Title : The Discovery of the First Red Geopolymer
Kawkab Kh al Naimi, Qatar University, Qatar
Title : Preliminary studies on phytochemical constituents of the leaves and fruits of Annona atemoya
Bassam Alkazman, The University of Sydney, Australia
Title : Selectively Inhibition of Magnolol on Th17 Cell Differentiation both in vitro and in vivo through Blocking STAT3 Signaling in CD4+ T Cells via Specifically Binding to STAT3 at SH2 Domain for Treating Multiple Sclerosis
Jian Yu Chen, Fujian University of Traditional Chinese Medicine, China
Title : Needles of Cupressus torulosa D. Don ex Lamb as a sustainable antioxidant and antidiabetic drug material
Radhika khanna, Forest Research Institute, India
Title : Targeted Vesicular Drug Delivery Insight
Swati Sachin Mutha, Vishwakarma University, India